AuntMinnieEurope.com staff writersArtificial IntelligenceMedic Vision’s iQMR AI software cleared in the U.K.Israeli imaging software developer Medic Vision has received clearance in the U.K. to market its iQMR AI-assisted MRI image enhancement technology.January 3, 2024MRIMagnet quench hazard prompts recall of legacy Philips MRI scannerPhilips is voluntarily recalling its Panorama 1-tesla HFO MRI scanner due to risk of a potential magnet quench hazard.January 2, 2024Nuclear MedicineIBA celebrates sale of the 100th Cyclone Kiube cyclotronIon Beam Applications (IBA) is celebrating the sale of the 100th Cyclone Kiube cyclotron.December 21, 2023Nuclear MedicineITM signs licensing agreement with Merck KGaAITM Isotope Technologies Munich has signed a licensing agreement with the life science business of Merck KGaA.December 14, 2023MRIGuerbet highlights marketing approval of Elucirem in EUGuerbet is highlighting that the European Commission has approved the marketing of Elucirem in the EU.December 12, 2023MRIEC approves Bracco's Vueway for European marketThe European Commission (EC) has granted marketing authorization in the EU for Bracco's Vueway.December 11, 2023Organized Radiology IssuesU.K. radiology continues to grapple with workforce crisisRadiologists in England are under pressure to meet a new performance target. Government must act to help them meet the growing workforce challenges, they say.December 11, 2023MRIResearchers build an MRI machine in just 4 daysA research team has built a functional MRI unit in 4 days. It took a set of 990 magnets arranged to produce a stable field, loops of wire for spatial encoding of the MR signal, an RF transmitter and receiver, and software.December 11, 2023CTPhilips'-managed CT consortium receives CAD grantPhilips’ public-private partnership COMBINE-CT consortium has received a $6.5-million-euro grant from the Innovative Health Initiative (IHI).December 8, 2023Nuclear MedicineTelix highlights first patient dosed with new renal cancer PET agentTelix Pharmaceuticals is highlighting that the first patient has been dosed with the company's TLX250-CDx for clear cell renal cell carcinoma.December 4, 2023Previous PagePage 43 of 926Next PageTop StoriesCTIR study: Keep aware of hydrophilic polymer embolizationClinicians, vendors, and regulators must collaborate to prevent hydrophilic polymer embolization, an underdiagnosed complication of endovascular interventions, European interventional radiology (IR) experts have asserted.CTRadiology mourns death of Ireland’s Barry KellyArtificial IntelligenceAI improves MRI diagnosis of prostate cancerMedical, Legal, and PracticeHow can we minimize errors caused by human factors?Sponsor ContentJoin us 26 June at 6 p.m. CET for a FREE webinar!